Alfred RuferOriginaire de Diessbach (BE), Alfred Rufer est né en 1951. Il obtient en 1976 le diplôme d'ingénieur électricien de l'EPFL et poursuit son activité dans le même établissement en tant qu'assistant à la chaire d'électronique industrielle. En 1993, il est nommé professeur-assistant au Laboratoire d'électronique industrielle. Au début 1996, il est nommé professeur extraordinaire. En 1978, il débute son activité dans l'industrie de l'électronique de grande puissance à la société ABB, Asea Brown Boveri à Turgi, où il contribue au développement d'entraînements réglés à fréquence variable. Dès 1985, il exerce la fonction d'assistant technique et de chef de groupe. De 1988 à 1991, il poursuit le développement de nouveaux systèmes d'électronique de puissance dans différents domaines d'application. A. Rufer est l'auteur et co-auteur de plusieurs demandes de brevet, ainsi que de plusieurs publications. De 1991 à 1992, il est chef d'un département de développement d'appareils d'électronique de réglage et de commande pour l'électronique de puissance. Durant son activité professionnelle dans l'industrie, il participe activement à l'enseignement technique dans plusieurs écoles d'ingénieurs.
Ambrogio FasoliAmbrogio FASOLI was born on November 10, 1964, in Milano, Italy. After a classical high school diploma (Maturità Classica) and graduation from the University of Milano, with the degree of Dottore in Fisica, he obtained his Phd at the Ecole Polytechnique Fédérale (EPFL) with a thesis on chaos in wave-particle interactions in plasmas, which was awarded the Best EPFL Thesis prize, in 1993. He then moved to the JET Joint Undertaking, the largest worlds fusion device, near Oxford, UK, to investigate Alfvén waves and burning plasma physics. In 1995-1996 he took a sabbatical leave, visiting several Universities and Research Institutes in Europe and in the USA, including three months at General Atomics in San Diego. In 1996-1997, during a second period at JET, he participated in the fusion power worlds record experiments in Deuterium-Tritium plasmas at JET. In 1997 he was nominated Assistant Professor in MIT Physics Department, where he led a basic plasma physics group and the international collaboration between MIT and JET. In 2001 Ambrogio FASOLI was nominated Assistant Professor of Physics at EPFL, Lausanne, Switzerland, and Professeur Boursier of the Swiss National Science Foundation. He became member of CRPP Directorate and took the leadership of CRPP basic plasma physics group and of the TCV tokamak, one of the major fusion experiments worldwide. At European level he was scientific coordinator for JET experiments, spokesperson for multi-machine experiments in the frame of International Tokamak Physics Activities, and Project Leader for a JET Enhancement project. In 2005 he became Associate Professor of Physics with tenure at EPFL, then member of EFDA Science and Technology Advisory Committee, and of the Steering Committee of the Association EURATOM-Swiss Confederation. From 2006 he was also Deputy Director, then from 2007 Executive Director of CRPP and from 2008 Full Professor of Physics at EPFL. For a number of years he was the Chair of the EPFL Physics Strategic Committee and a member of the Directorate of the EPFL School of Sciences. Since the summer of 2014 Professor FASOLI was the sole Director of CRPP. He now represents Switzerland in the EUROfusion General Assembly and Bureau, and in the Governing Board for Fusion for Energy. He is member of the EUROfusion DEMO project Board, of the Scientific Board of the Helmotz Virtual Institute on Advanced Microwave Diagnostics, of the European Delegation for the Cooperation between Euratom and the Government of India in Fusion Energy Research, of the European Consortium for the development of the ITER gyratron (EGYC), and participates to numerous international review panels. He chairs the FuseNet Academic Council, the International Advisory Panel for the Laboratory of Excellence Plas@Par in the Sorbonne Universities, the European Consortium for the construction of the ITER microwave Upper Launcher (ECHUL), and the Promotion Committee of the EPFL Faculty of Basic Sciences. He is one the three European representatives in the International Tokamak Physics Activities Coordinating Committee, advising ITER, and the Editor-in-Chief of the IAEA journal Nuclear Fusion. Since January 2019, Ambrogio Fasoli is the Chair of the General Assembly, i.e. the president of EUROfusion, the European Consortium for Development of Fusion Energy. Professor FASOLI is a Fellow of the American Physical Society and since 2001 a Visiting Professor at MIT Physics Department. He is the Director of the Swiss Plasma Center.
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
